Psychotropic medication use in children and adolescents: review of outpatient treatments

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Düşünen Adam: The Journal of Psychiatry and Neurological Sciences

• Publication date

  2018-03-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.5350/DAJPN2018310107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Psychopharmacological Prescriptions in Children and Adolescents in Germany.

  2016cited by this paper
• Risperidone use in preschool children with aggressive and destructive behavioral symptoms

  2015cited by this paper
• A report by Turkish Association for Psychopharmacology on the psychotropic drug usage in Turkey and medical, ethical and economical consequences of current applications -

  2013cited by this paper
• Child and adolescent mental health worldwide: evidence for action.

  2011cited by this paper
• Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.

  2011cited by this paper
• Rise in psychotropic drug prescribing in children and adolescents during 1992–2001: a population-based study in the UK

  2009cited by this paper
• Broadened use of atypical antipsychotics: safety, effectiveness, and policy challenges.

  2009cited by this paper
• Medication Adherence: A Review of the Literature and Implications for Clinical Practice

  2009cited by this paper
• Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomes.

  2008cited by this paper
• Clinical Characteristics of Adolescent Admissions to The Child and Adolescent Psychiatry Outpatient Clinic

  2008cited by this paper
• Adherence to Antidepressant Treatment Among Privately Insured Patients Diagnosed With Depression

  2007cited by this paper
• The worldwide prevalence of ADHD: a systematic review and metaregression analysis.

  2007cited by this paper
• National trends in the outpatient treatment of children and adolescents with antipsychotic drugs.

  2006cited by this paper
• Assessment of Adherence Measures with Different Stimulants Among Children and Adolescents

  2005cited by this paper
• Current Prescribing Patterns in Outpatient Child and Adolescent Psychiatric Practice in Central New York

  2005cited by this paper
• Alterations in medication in a child and adolescentpsychiatric outpatient clinic

  2005cited by this paper
• New users of antipsychotic medications among children enrolled in TennCare.

  2004cited by this paper
• Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults.

  2004cited by this paper
• A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone.

  2003cited by this paper
• Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization.

  2003cited by this paper
• Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.

  2002cited by this paper
• National trends in the use of psychotropic medications by children.

  2002cited by this paper
• Enhancing drug compliance in lipid-lowering treatment.

  2000cited by this paper
• Trends in the prescribing of psychotropic medications to preschoolers.

  2000cited by this paper
• A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD.

  1999cited by this paper
• Childhood and adolescent depression: a review of the past 10 years. Part II.

  1996cited by this paper
• Adherence to treatment and health outcomes.

  1993cited by this paper
• Antidepressant treatments in children and adolescents. I. Affective disorders.

  1993cited by this paper
• Compliance in Health Care

  1979cited by this paper

• Clinical Profiles and Medication Predictors in Early Childhood Psychiatric Referrals: A 10-Year Retrospective Study

  2025cites this paper
• Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review

  2023cites this paper
• Current Pattern of Psychiatric Comorbidity and Psychotropic Drug Prescription in Child and Adolescent Patients

  2019cites this paper